Cinemark price target raised to $36 from $35 at Roth Capital
Roth Capital raised the firm’s price target on Cinemark (CNK) to $36 from $35 and keeps a Buy rating on the shares. Following better than expected Q4 results, Cinemark remains in a good position to benefit from an improved movie slate in 2026 and 2027, the analyst tells investors in a research note. Box office growth should fuel margin expansion, higher free cash flow, and increased capital returns, the firm adds.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.